Apply on Employer Site

Volastra Therapeutics · 11 hours ago

Scientist/Senior Scientist, Preclinical Development and Translational Science

New York, NY

Full-time

Onsite

Mid, Senior Level

$120K/yr - $180K/yr

5+ years exp

Volastra Therapeutics, Inc. is a clinical-stage oncology biotech company based in New York City, pioneering novel approaches to treating cancer by targeting chromosomal instability. The Scientist/Senior Scientist of Preclinical Development and Translational Science will be responsible for executing preclinical development programs and conducting translational science investigations while collaborating with various teams to support clinical trial biomarker capabilities.

BiotechnologyLife ScienceMedical

H1B Sponsor Likely

Responsibilities

In collaboration with other members of the Translational Science and the Discovery Science team, design and execute experimental plans to answer important translational questions to inform clinical development plans

Coordinate and oversee studies at contract research organizations

Execution and development of existing and/or new assays and assay strategies related to biomarker application and validation

Coordinate activities and timelines with Development teams to ensure seamless execution of biomarker capabilities to support clinical trials

Work closely with relevant team members to analyze, interpret and communicate translational results

Assist in preparation of relevant documents and reports including meeting presentations, biomarker reports, and regulatory submission documents

Qualification

Preclinical developmentClinical oncology biomarkerCell-based assaysMolecular biologyHistologyVivo mouse experienceAntibody drug conjugatesBiomarker assay developmentProject management with CROsCommunication skillsOrganizational skillsProblem-solving skills

Required

MS in related field

2+ years of industry experience in preclinical development and clinical oncology biomarker

5+ years of hands-on lab experience with a range of relevant research techniques including cell-based assays, molecular biology, and histology

Knowledge of antibody drug conjugates (ADC) biology and broad experience with in vitro and in vivo ADC testing

Experience in the development and validation of biomarker assays suitable for clinical samples

Track record of successfully managing external projects with CRO's from scoping to final data delivery

Understanding of the drug development process from target identification to marketing authorization

Basic understanding of regulatory aspects of medical diagnostics

Excellent communication, organizational, and problem-solving skills

Preferred

PhD

In vivo mouse experience

Company

Volastra Therapeutics

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

Founded in 2019

New York, New York, USA

11-50 employees

https://volastratx.com/

H1B Sponsorship

Volastra Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2025 (1)

2023 (1)

2022 (1)

Funding

Current Stage

Early Stage

Total Funding

$149.1M

Key Investors

Polaris Partners

2025-09-23Series A· $30.1M

2024-05-30Series Unknown· $15M

2023-03-07Series A· $60M

Leadership Team

David Southwell

Chief Executive Officer

Recent News

Crain's New York Business

Harlem startup raises $30M to advance cancer treatments

2025-09-26

Business Wire

KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025-2030 - ResearchAndMarkets.com

2025-08-01

Research and Markets

KIF18A Targeting Therapies Market Research 2025-2030 | Over 10 KIF18A Therapies Currently in Development

2025-07-24

Company data provided by crunchbase